Research Article

Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes

Table 1

(a)

Reagent

Perillaldehyde (PAH)Tokyo Chemical Industry (Tokyo, Japan)
Dulbecco’s modified Eagle’s mediumSigma-Aldrich (St. Louis, MO, USA)
Benzo(a)pyrene (BaP)
Dimethyl sulfoxide (DMSO)
EthanolWako Laboratory Chemicals (Osaka, Japan)
0.05% (w/v) trypsin-0.53 mM EDTA-4Na solution

(b)

Antibody

Anti-AHR rabbit polyclonal antibody (H-211)Santa Cruz Biotechnology (Dallas, TX, USA)
Anti-NRF2 rabbit polyclonal antibody (H-300)
UtraCruzTM mounting medium containing 4,6-diamidino-2-phenylindole
Horseradish peroxidase-conjugated green-fluorescent Alexa Flour® 488Molecular Probes (Eugene, OR, USA)
5-(and −6)-Carboxy-2,7-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA)

(c)

Kit

RNeasy Mini kitQiagen (Hilden, Germany)
PrimeScriptTM RT reagentTakara Bio (Kusatsu, Japan)
SYBR® Premix Ex TaqTM II
Quantikine human CCL2/MCP1 ELISA kitR&D Systems (Minneapolis, MN, USA)
Quantiline human IL-1β ELISA kit
CCK-8 assay kitDojindo Laboratories (Kumamoto, Japan)

(d)

siRNA

NRF2 siRNA (s9492)Ambion (Austin, TX, USA)
Control siRNA (negative control number 1)
Lipofectamine® RNAiMAX Reagent (RNAiMAX)Invitrogen™ (Carlsbad, CA, USA)